ICU Medical, Inc. Expands Its Relationship With MedAssets Supply Chain Systems

MedAssets to Begin Offering New ICU Oncology Products

Agreement Extended An Additional 3 Years On Existing Product Offerings
SAN CLEMENTE, Calif., June 19, 2008 (PRIME NEWSWIRE) -- ICU Medical, Inc.,
(Nasdaq:ICUI), a leading low cost manufacturer of safe medical connectors,
custom medical products and critical care devices, today announced that it has
extended its current agreement for Clave IV Sets and expanded the product
offering to include its Safe Handling oncology product line with MedAssets
Supply Chain Systems, a MedAssets company, (Nasdaq:MDAS). MedAssets Supply Chain
Systems is one of the nation's largest group purchasing organizations, providing
innovative solutions for healthcare providers to improve their margins and cash
flow. This expanded agreement will continue to offer MedAssets's customers ICU's
products which provide better patient outcomes and cost reduction as well as
cost avoidance.

Under the terms of the amended agreement, MedAssets will continue to co-market
ICU Medical's market leading CLAVE and MicroClave Needleless IV systems along
with Specialty custom sets for a minimum of three additional years, through
September 31, 2011. The two companies will also collaborate on customized
programs designed to bring significant value to MedAssets customers.

Rich Costello, ICU Medical's Vice President of Sales, stated, "We look forward
to continuing to grow our relationship with MedAssets and believe this expanded
agreement will create additional opportunities for growth and validates the
growing need for our products throughout the MedAssets customer base."

Additionally, MedAssets will begin offering ICU's new full line of safe handling
oncology products featuring the Spiros & Genie to its extensive network of
oncology service customers. These products are designed to provide safety for
both the healthcare professional and the patient by reducing exposure to
hazardous drugs and by reducing blood stream infections which are costing the
healthcare industry billions of dollars a year.

"ICU Medical has been a long-standing contracted vendor with MedAssets and we
are very pleased with the value they offer our customers," said Mark Miriani,
President of MedAssets Supply Chain Systems. "We continually strive to offer our
customers products that will provide the best patient and healthcare employee
safety and quality of care in addition to superior cost savings, and ICU Medical
helps achieve this goal. We are very excited about introducing additional ICU
Medical products to our customers and look forward to a long-term and mutually
beneficial relationship."

Prior to expanding the agreement with MedAssets Supply Chain Systems, ICU
Medical underwent MedAssets's rigorous nine-step contract selection process,
including thorough review by its research team and the MedAssets Contracting
Advisory Team, to determine that ICU Medical's new and existing products met the
needs of its customers.

About MedAssets

MedAssets (Nasdaq:MDAS) partners with healthcare providers to improve their
financial strength by implementing integrated spend management and revenue cycle
solutions that help control cost, improve margins and cash flow, increase
regulatory compliance, and optimize operational efficiency. MedAssets serves
more than 125 health systems, 3,300 hospitals and 30,000 non-acute care
healthcare providers. For more information, visit www.medassets.com.

About ICU Medical, Inc.

ICU Medical, Inc. (Nasdaq:ICUI) is a leader in the development, manufacture and
sale of proprietary, disposable medical connection systems for use in vascular
therapy applications. Our devices are designed to protect patients from catheter
related bloodstream infections and healthcare workers from exposure to
infectious diseases through accidental needle sticks. We are also a leader in
the production of custom I.V. systems and we incorporate our proprietary
products into many of those custom I.V. systems. For more information, visit
www.icumed.com.

The foregoing statement concerning Management's expectation with respect to
future results is a forward-looking statement based upon the best information
currently available to Management and assumptions Management believes are
reasonable, but Management does not intend the statement to be a representation
as to future results. Future results are subject to risks and uncertainties,
including the risk factors described in the Company's filings with the
Securities and Exchange Commission, which include those in the Form 10-K for the
year ended December 31, 2007 and Form 10-Q for the quarter ended March 31, 2008.
Actual results in the future may differ materially from Management's current
expectations.

-0-
CONTACT: ICU Medical, Inc.
Scott Lamb, Chief Financial Officer
(949) 366-2183

ICR, Inc.
John F. Mills, Senior Managing Director
(310) 954-1100